Cargando…
Clinical features and treatment of squamous cell carcinoma of the breast
OBJECTIVES: Data on breast squamous cell carcinoma (SCC) are rare. The aim of this study was to analyze the clinical characteristics and to explore the rational treatment of patients with breast SCC. PATIENTS AND METHODS: We conducted a retrospective review of breast SCC cases treated at our center...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892827/ https://www.ncbi.nlm.nih.gov/pubmed/27313463 http://dx.doi.org/10.2147/OTT.S95128 |
_version_ | 1782435458027880448 |
---|---|
author | Zhang, Ximei Zhang, Baozhong Zang, Fenglin Zhao, Lujun Yuan, Zhiyong Wang, Ping |
author_facet | Zhang, Ximei Zhang, Baozhong Zang, Fenglin Zhao, Lujun Yuan, Zhiyong Wang, Ping |
author_sort | Zhang, Ximei |
collection | PubMed |
description | OBJECTIVES: Data on breast squamous cell carcinoma (SCC) are rare. The aim of this study was to analyze the clinical characteristics and to explore the rational treatment of patients with breast SCC. PATIENTS AND METHODS: We conducted a retrospective review of breast SCC cases treated at our center from 1966 to 2014. The majority of these patients received primary surgery followed by adjuvant chemoradiotherapy, whilst four elderly patients had lumpectomy only. RESULTS: Patients with breast SCC were usually women, and large masses, large proportion of early stage disease, low levels of estrogen receptor expression, less frequent axillary lymph nodes involvement, and unfavorable prognosis were common. The 5-year overall survival and progression-free survival of all patients were 67.2% and 57.8%, respectively. Axillary nodal involvement was a significant prognostic factor for survival. CONCLUSION: The current results indicated that breast SCC is clinically aggressive and the outcomes were poor. Distant metastasis was the main failure pattern. New strategies will be needed because of the poor outcomes. |
format | Online Article Text |
id | pubmed-4892827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48928272016-06-16 Clinical features and treatment of squamous cell carcinoma of the breast Zhang, Ximei Zhang, Baozhong Zang, Fenglin Zhao, Lujun Yuan, Zhiyong Wang, Ping Onco Targets Ther Original Research OBJECTIVES: Data on breast squamous cell carcinoma (SCC) are rare. The aim of this study was to analyze the clinical characteristics and to explore the rational treatment of patients with breast SCC. PATIENTS AND METHODS: We conducted a retrospective review of breast SCC cases treated at our center from 1966 to 2014. The majority of these patients received primary surgery followed by adjuvant chemoradiotherapy, whilst four elderly patients had lumpectomy only. RESULTS: Patients with breast SCC were usually women, and large masses, large proportion of early stage disease, low levels of estrogen receptor expression, less frequent axillary lymph nodes involvement, and unfavorable prognosis were common. The 5-year overall survival and progression-free survival of all patients were 67.2% and 57.8%, respectively. Axillary nodal involvement was a significant prognostic factor for survival. CONCLUSION: The current results indicated that breast SCC is clinically aggressive and the outcomes were poor. Distant metastasis was the main failure pattern. New strategies will be needed because of the poor outcomes. Dove Medical Press 2016-05-27 /pmc/articles/PMC4892827/ /pubmed/27313463 http://dx.doi.org/10.2147/OTT.S95128 Text en © 2016 Zhang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Zhang, Ximei Zhang, Baozhong Zang, Fenglin Zhao, Lujun Yuan, Zhiyong Wang, Ping Clinical features and treatment of squamous cell carcinoma of the breast |
title | Clinical features and treatment of squamous cell carcinoma of the breast |
title_full | Clinical features and treatment of squamous cell carcinoma of the breast |
title_fullStr | Clinical features and treatment of squamous cell carcinoma of the breast |
title_full_unstemmed | Clinical features and treatment of squamous cell carcinoma of the breast |
title_short | Clinical features and treatment of squamous cell carcinoma of the breast |
title_sort | clinical features and treatment of squamous cell carcinoma of the breast |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892827/ https://www.ncbi.nlm.nih.gov/pubmed/27313463 http://dx.doi.org/10.2147/OTT.S95128 |
work_keys_str_mv | AT zhangximei clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast AT zhangbaozhong clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast AT zangfenglin clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast AT zhaolujun clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast AT yuanzhiyong clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast AT wangping clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast |